With the development of biomaterials science and the growing demand for intelligent systems for controlled drug delivery, the use of smart polymers such as polyelectrolytes has become increasingly important. Polyelectrolytes are polymers with ionic groups in the main or side chain that exhibit ionic behavior in aqueous environments. These compounds interact with charged drugs, exhibit high bioavailability, and modulate their response to environmental factors, making them effective drug delivery vehicles.
What are electroactive polymers?
Electrophilic polymers are polymers that contain ionizable groups. These groups can be acidic (anionic electrophilic polymers) , basic (cationic electrophilic polymers) , or diionic (diionic ions) . These compounds ionize and acquire a surface charge when they come into contact with an aqueous medium.
Examples of widely used electroactive polymers:
-
Polyacrylic acid (PAA)
-
Chitosan
-
Polystyrene sulfonate (PSS)
Unique properties of electroactive polymers in drug delivery
1. The ability to carry medication during pregnancy.
Electroactive polymers are able to bind charged drug molecules (such as proteins, RNA, and antibiotics) via electrostatic interactions. This property enables efficient drug loading and prevents unwanted drug release.
2. pH reaction
Many electroactive polymers are pH-sensitive, meaning they can change their structure and release drugs in acidic or alkaline environments such as the stomach, blood, or inside cells.
3. Option of a controlled start
By designing the structure of a nanoparticle, nanocapsule or microgel, it is possible to control the release of a drug at a specific rate over different periods of time.
4. Biodegradability and biocompatibility
Biologically derived electroactive polymers such as chitosan or alginate exhibit high compatibility with the human body and can be broken down there without causing toxic effects.
Mechanisms of drug delivery using electroactive polymers
a) Adsorption
The drug is adsorbed onto the surface of electrolytic polymer particles via ionic or hydrogen bonds. This method is simple and easy to control.
b) Packaging
Drugs are encapsulated in polymer structures such as microgels or nanocapsules. Electroactive polymers provide a protective physical structure.
c) Breakable covalent bonds
In some cases, the drug is linked to the polymer via a chemical bond that breaks under certain conditions (pH, enzymes, temperature) and releases the drug.
kit
Common electroactive polymer structures for drug delivery
1. Polyelectrolyte nanoparticles
Small particles with a charged surface that hold drugs on or in their surface.
2. Encapsulate layer by layer
These structures are formed by alternating layers of cationic and anionic polyelectrolytes based on the active ingredient. The rate of drug release can be controlled by adjusting the layer thickness.
3. Electropolymer hydrogel
These water-swollen gel structures can contain drugs in a polymer matrix and release them in response to environmental conditions.
Factors that affect the efficiency of drug delivery
1. Surface charge of electroactive polymers
The higher the charge of the polymer, the greater its ability to absorb and store drugs. However, in some cases, an excessive charge can have toxic effects on cells.
2. Molecular weight
Polymers with higher molecular weights have a stronger structure and are released more slowly.
3. Response to stimuli
Electroactive polymers that are sensitive to pH, temperature, or enzymes can release drugs only at specific locations in the body (e.g., in tumors or inflammatory cells).
4. Viscosity and rheological properties
Rheological properties play a crucial role in injectable and oral dosage forms. Electrolytic polymers can modify the viscosity, thereby improving the drug’s injectability or dispersion.
Clinical and research applications
1. Cancer treatment
Electroactive polymers can deliver chemotherapeutic agents directly to cancer cells, thus preventing them from damaging healthy tissue. For example, chitosan nanoparticles have been used to deliver doxorubicin for the treatment of liver cancer.
2. Vaccines
The use of electroactive polymers to transfer antigens to immune cells could contribute to the development of next-generation vaccines.
3. Antimicrobial drugs
Cationic polymers such as polyethyleneimine or chitosan have antimicrobial properties that can kill bacteria or deliver antibiotics to the site of infection.
4. Transmission of genes and RNA
Electrophilic polymers play a crucial role in the transport of nucleic acids (e.g., DNA, RNAi) because they protect nucleic acids from environmental degradation and transport them into cells.
Advantages and problems
| To use | Attempt |
|---|---|
| Drug exposure during pregnancy | Highly charged polymers can be toxic. |
| Easy adjustment of pH and temperature | Instability of some biological environments |
| Engineering expertise and environmentally friendly design | It is difficult to achieve large-scale production and ensure consistent quality. |
| For injection and oral administration | In some cases, premature stomach or blood damage can occur. |
Finally
Electroactive polymers are among the most widely used and adaptable materials for drug delivery systems. Their electrostatic properties, sensitivity to physiological stimuli, and nanotechnology capabilities make them ideal for the development of intelligent drug delivery systems. Despite challenges such as their in vivo stability and toxicity, intensive research is being conducted to improve the efficacy and safety of these materials. The future of drug delivery depends on intelligent materials that enable more precise, safer, and more effective treatments, and electroactive polymers are among the leading products in this field.